Antibody Mediated Rejection clinical trials at University of California Health

• VIRTUUS Children's Study

  open to eligible people ages 2-18

  The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.

  at UCLA UCSD

Last updated: September 13, 2021